FARON PHARMACEUTICALS OY
FARN | IL
Overview
Corporate Details
- ISIN(s):
- FI4000153309
- LEI:
- 7437009H31TO1DC0EB42
- Country:
- Finland
- Address:
- Joukahaisenkatu 6, FI-20520 TURKU
- Website:
- N/A
- Sector:
- Consumer Staples
- Industry:
- Beverages
Description
Fever-Tree, the world's leading premium mixer company, offers a range of tonics, gingers, sodas, and more in over 75 countries. Our mission is to create exceptional drinks experiences using high-quality, natural ingredients and expert manufacturing. We're focused on strengthening distribution, expanding into new markets, and developing innovative products.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-12 08:00 |
Regulatory News Service
Faron Pharmaceuticals presents updated Phase II data from BEXMAB Study at EHA 2…
|
English | 13.2 KB | |
| 2025-06-05 17:00 |
Directors' Dealings
Faron Pharmaceuticals Ltd: Director/PCA Dealing and Donation of Shares to Found…
|
English | 28.6 KB | |
| 2025-06-03 13:00 |
Regulatory News Service
Faron Pharmaceuticals Ltd: Registration of New Shares
|
English | 8.3 KB | |
| 2025-06-03 08:00 |
Share Issue/Capital Change
Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rig…
|
English | 9.4 KB | |
| 2025-06-02 08:00 |
Earnings Release
Faron Pharmaceuticals presents Phase II data from BEXMAB Study at ASCO 2025
|
English | 13.2 KB | |
| 2025-05-30 08:00 |
Earnings Release
Faron announces publication of full Phase I BEXMAB study data in Lancet Haemato…
|
English | 10.3 KB | |
| 2025-05-27 18:00 |
Capital/Financing Update
Faron Pharmaceuticals Ltd: Issue of Treasury Shares to the Company
|
English | 8.8 KB | |
| 2025-05-27 08:00 |
Regulatory News Service
Faron’s Bexmarilimab demonstrates immune-activating and drug-sensitizing potent…
|
English | 12.2 KB | |
| 2025-05-23 08:00 |
Regulatory News Service
Faron announces new data that highlight patient populations with cancer that ar…
|
English | 13.9 KB | |
| 2025-05-21 08:00 |
Board/Management Change
Faron Appoints Ralph Hughes as Chief Business Officer (CBO)
|
English | 8.3 KB | |
| 2025-05-15 08:00 |
Regulatory News Service
Faron Announces Acceptance of Bexmarilimab Data for Oral Presentation at EHA 20…
|
English | 8.6 KB | |
| 2025-05-14 15:00 |
Regulatory News Service
Faron Pharmaceuticals Ltd: Grant of Options
|
English | 22.5 KB | |
| 2025-05-12 08:00 |
Earnings Release
Faron Pharmaceuticals presents promising Phase 1/2 data from BEXMAB Study at MD…
|
English | 12.6 KB | |
| 2025-04-24 08:00 |
Regulatory News Service
Faron announces acceptance of bexmarilimab Phase II data for oral presentation …
|
English | 10.2 KB | |
| 2025-04-15 08:00 |
Earnings Release
Inside Information: Faron Announces Positive Phase II results in higher-risk my…
|
English | 7.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
FuturAqua Mineral Water Production and AM Plc | Hungary | FUTUR | |
|
Grozd AD | North Macedonia | GRZD | |
|
JDE Peet's N.V. | Netherlands (Kingdom of the) | JDEP | |
|
Kofola CescoSlovensko A.S. | Czechia | KOFOL | |
|
Kristal Kola Ve Mesrubat Sanayi Ticaret AS | Türkiye | KRSTL | |
|
Krynica Vitamin S.A. | Poland | KVT | |
|
Miko N.V. | Belgium | MIKO | |
|
Mineralbrunnen Überkingen AG | Germany | MUT3 | |
|
Misitano & Stracuzzi S.p.A. | Italy | MS | |
|
NEXTEQ PLC | United Kingdom | NXQ |